Navigation Links
NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
Date:2/18/2011

adila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. For more information about Novavax, please visit www.novavax.com.

Cautionary Note Regarding Forward-Looking Statements

Statements herein relating to future business performance, conditions or strategies and other business matters, including our assessment of the results of our products in clinical trials are forward-looking statements. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. We caution readers not to place significant reliance on the forward-looking statements contained in this release. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include, among other things,  the following: our ability to progress any product candidates in clinical trials; the scope, initiation, rate and progress of our clinical trials and other research and development activities; even with positive data from clinical trials, the product candidate may not prove to be safe and efficacious; decisions by regulatory agencies may delay or prevent our development programs or increase the costs of such programs; regulatory approval is needed before any we can initiate clinical trials on our vaccines; regulatory approval is needed before any vaccines can be sold in or outside the United States and, to date, no governmental authority has approved any of our vaccine candidates for sale; we have not manufactured any of our vaccine candidates at a commercial level; we utilize a unique manufacturing process and the scale-up of that process may prove difficult and/or costly; our dependence on third parties to manufacture and distribute our vaccines; risks associated with conducting business outside of the United States;
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NOVAVAX to Present H1N1 VLP Influenza Vaccine Clinical Data at 7th World Health Organization (WHO) Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials
2. NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial
3. NOVAVAX to Present at Lazard 7th Annual Healthcare Conference
4. NOVAVAX Reports Third Quarter 2010 Financial Results
5. Novavax to Report Third Quarter 2010 Financial Results on November 5, 2010
6. NOVAVAX to Present at BIO Investor Forum
7. NOVAVAX to Present at Stifel Nicolaus Conference
8. NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures
9. NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines
10. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
11. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  Amgen (NASDAQ: ... commenced termination of its participation in the ... (LON:AZN, STO:AZN and NYSE: AZN ).  ... development for patients with moderate-to-severe plaque psoriasis, ... was based on events of suicidal ideation ...
(Date:5/22/2015)... May 22, 2015 The Assistance Fund announces ... program provides financial assistance for copay to individuals diagnosed ... announce the addition of the Melanoma Copay Assistance Program ... McGreevy , executive director. "With each additional program we ... a world where no one is denied access to ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
(Date:5/25/2015)... Garden City, NY (PRWEB) May 26, 2015 ... honors Lisa Ferrara, Ph.D., as a ... Circle. She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more than ... "I'm pleased to welcome Lisa into this exceptional group ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 According to ... ), market growth in hip external fixation market is ... aging U.S. population and advancements in infection prevention technologies. ... These fractures are currently accounting for the largest total ... associated with falls and accidents. As a result, the ...
(Date:5/25/2015)... 25, 2015 Join Fiona's Soccer Camp at ... instructional clinic. Irish National Player, Fiona O'Sullivan will be ... a taste of her coaching style. Fiona has three camps ... in Novato are at Lynwood Elmentary School (June 15-19) and ... School - June 6th, 2015 - 1:00-3:00pm. Bring a Soccer ...
(Date:5/24/2015)... 25, 2015 Pacific Prime has announced that they ... looking at the cost of individual international health insurance. Titled: ... looks at the cost of health insurance in six top expat ... Hong Kong , Singapore , ... UAE , the UK , Article 2 ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 Scientists with ... paper on air quality compliance issues that may have ... workers. Surviving Mesothelioma has just posted an article on ... , The group found airborne asbestos levels well ... collected between 1984 and 2011. , “Asbestos compliance sampling ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lisa Ferrara, Ph.D., CEO of OrthoKinetic Technologies, Into its VIP Professional Woman of the Year Circle 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2
... Campaign will explain serious threat of re-emerging diseases, AAP ... A new educational campaign to reinforce the importance of ... Week, April 24 to May 1. , The program, ... without vaccinations, infants and children are at risk for ...
... ... prepare to wave goodbye to winter weight. , ... (PRWEB) April 27, 2010 -- World famous diet expert Tony Ferguson is collaborating ... of healthy eating solutions to the High Street., , ,Overindulgence at Christmas, cold weather comfort eating, ...
... ... to create and deploy their own custom branded mobile application to iPhone, iPad, and Android ... ... announced the debut of its platform that allows businesses to build and deploy ...
... ... SysML Applied™" workshops will meet the needs of clients that are demanding increased ... are available immediately in a tool-independent edition as well as tool-customized editions for ... ...
... participate in randomized clinical trials hoping to benefit from ... the same condition. However, rules and regulations are ... are limited and risks may be much less than ... is no question that research participants need protection," write ...
... Tiny, melanin-covered nanoparticles may protect bone marrow from the ... Albert Einstein College of Medicine of Yeshiva University who ... particles into human patients may hold promise in the ... of the International Journal of Radiation Oncology, Biology ...
Cached Medicine News:Health News:Educational Program Urges Parents to Immunize Kids 2Health News:Healthy Diet From Down Under To Help Brits Shape Up For Summer 2Health News:Healthy Diet From Down Under To Help Brits Shape Up For Summer 3Health News:Healthy Diet From Down Under To Help Brits Shape Up For Summer 4Health News:Snowflake Mobile™ Launches Platform for Creating and Deploying Mobile Apps 2Health News:PivotPoint Technology Launches Advanced SysML Training Services 2Health News:PivotPoint Technology Launches Advanced SysML Training Services 3Health News:Novel nanoparticles prevent radiation damage 2Health News:Novel nanoparticles prevent radiation damage 3Health News:Novel nanoparticles prevent radiation damage 4
... disc test for detecting and grading ... minutes for quantitative estimation of saturation ... sensitive to and specific for differences ... Combined with Ishiharas pseudo-isochromatic plates, discriminates ...
Gas powered, single use, reloadable, laparoscopic 15 mm linear cutting stapler for resection, transection and anastomosis with titanium staples....
12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Single Use Loading Units (SULU's) with Titanium Staples for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Medicine Products: